Novocure Total Current Liabilities from 2010 to 2025
| NVCR Stock | USD 18.97 0.53 2.87% |
Total Current Liabilities | First Reported 2013-12-31 | Previous Quarter 735 M | Current Value 756.4 M | Quarterly Volatility 151.5 M |
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.2 M, Selling General Administrative of 97.7 M or Selling And Marketing Expenses of 251 M, as well as many indicators such as Price To Sales Ratio of 5.04, Dividend Yield of 0.0 or PTB Ratio of 13.33. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
Novocure | Total Current Liabilities |
Latest Novocure's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Novocure over the last few years. Total Current Liabilities is an item on Novocure balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Novocure are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Novocure's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Novocure Total Current Liabilities Regression Statistics
| Arithmetic Mean | 155,707,488 | |
| Geometric Mean | 64,305,434 | |
| Coefficient Of Variation | 159.32 | |
| Mean Deviation | 158,204,106 | |
| Median | 64,560,000 | |
| Standard Deviation | 248,068,702 | |
| Sample Variance | 61538.1T | |
| Range | 778.6M | |
| R-Value | 0.73 | |
| Mean Square Error | 30814.9T | |
| R-Squared | 0.53 | |
| Significance | 0 | |
| Slope | 38,027,154 | |
| Total Sum of Squares | 923071.2T |
Novocure Total Current Liabilities History
About Novocure Financial Statements
Novocure shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 756.4 M | 794.2 M |
Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.